Privia Health Group, Inc. (PRVA)
NASDAQ: PRVA · Real-Time Price · USD
21.74
-0.27 (-1.23%)
Feb 5, 2026, 2:17 PM EST - Market open
Privia Health Group Analyst Ratings
Total Analysts
14
Consensus Rating
Strong Buy
Price Target
$30.50
Upside
+40.29%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Initiates $31 | Buy | Initiates | $31 | +42.59% | Jan 9, 2026 |
| Stephens & Co. | Stephens & Co. | Buy Reiterates $32 | Buy | Reiterates | $32 | +47.19% | Dec 4, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $32 → $33 | Buy | Maintains | $32 → $33 | +51.79% | Nov 13, 2025 |
| BMO Capital | BMO Capital | Buy Initiates $30 | Buy | Initiates | $30 | +37.99% | Nov 13, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $32 → $34 | Strong Buy | Maintains | $32 → $34 | +56.39% | Nov 12, 2025 |
| Barclays | Barclays | Hold Maintains $22 → $23 | Hold | Maintains | $22 → $23 | +5.80% | Nov 10, 2025 |
| Truist Securities | Truist Securities | Strong Buy Reiterates $30 → $31 | Strong Buy | Reiterates | $30 → $31 | +42.59% | Nov 10, 2025 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $28 → $30 | Buy | Maintains | $28 → $30 | +37.99% | Nov 7, 2025 |
| Citizens | Citizens | Buy Maintains $30 → $31 | Buy | Maintains | $30 → $31 | +42.59% | Nov 7, 2025 |
| Barclays | Barclays | Hold Maintains $21 → $22 | Hold | Maintains | $21 → $22 | +1.20% | Oct 9, 2025 |
| Stephens & Co. | Stephens & Co. | Buy Reiterates $32 | Buy | Reiterates | $32 | +47.19% | Sep 24, 2025 |
| Stephens & Co. | Stephens & Co. | Buy Reiterates $32 | Buy | Reiterates | $32 | +47.19% | Sep 4, 2025 |
| JMP Securities | JMP Securities | Buy Maintains $29 → $30 | Buy | Maintains | $29 → $30 | +37.99% | Aug 29, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $35 → $36 | Buy | Maintains | $35 → $36 | +65.59% | Aug 11, 2025 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $30 → $28 | Buy | Maintains | $30 → $28 | +28.79% | Jul 9, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $29 → $32 | Buy | Maintains | $29 → $32 | +47.19% | May 28, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.